Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Grace Therapeutics (GRCE)

NASDAQ:GRCE

GRCE

Grace Therapeutics

RESEARCH TOOLSreports

Grace Therapeutics (GRCE) Ratios

Compare

1,173 Followers

Grace Therapeutics Ratios

GRCE's free cash flow for Q2 2026 was C$0.00. For the 2026 fiscal year, GRCE's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	13.89	11.77	14.26	14.26	8.59
Quick Ratio	13.89	11.77	14.26	14.26	8.59
Cash Ratio	13.54	11.47	13.66	13.66	8.17
Solvency Ratio	-2.08	-1.78	-1.11	-1.11	-3.79
Operating Cash Flow Ratio	-9.66	-7.72	-7.32	-7.32	-4.67
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	0.00
Net Current Asset Value	C$ 13.54M	C$ 17.33M	C$ 12.45M	C$ 12.45M	C$ 18.12M
Leverage Ratios
Debt-to-Assets Ratio	0.00	0.00	0.00	0.00	<0.01
Debt-to-Equity Ratio	0.00	0.00	0.00	0.00	<0.01
Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	<0.01
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.06	1.08	1.19	1.19	1.16
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Interest Coverage Ratio	0.00	0.00	0.00	0.00	0.00
Debt to Market Cap	0.00	0.00	0.00	0.00	0.00
Interest Debt Per Share	0.00	0.00	0.00	0.00	0.07
Net Debt to EBITDA	2.08	1.33	2.03	2.03	1.51
Profitability Margins
Gross Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Pretax Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Continuous Operations Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Per EBT	82.81%	74.94%	87.52%	87.52%	81.64%
EBT Per EBIT	75.50%	76.55%	114.26%	114.26%	99.65%
Return on Assets (ROA)	-11.74%	-13.29%	-17.53%	-17.53%	-53.62%
Return on Equity (ROE)	-12.76%	-14.36%	-20.82%	-20.82%	-62.44%
Return on Capital Employed (ROCE)	-19.14%	-23.81%	-17.95%	-17.95%	-68.89%
Return on Invested Capital (ROIC)	-15.85%	-17.84%	-15.71%	-15.71%	-56.18%
Return on Tangible Assets	-45.17%	-42.10%	-53.48%	-53.48%	-142.11%
Earnings Yield	-12.85%	-34.72%	-57.42%	-57.42%	-189.58%
Efficiency Ratios
Receivables Turnover	0.00	0.00	0.00	0.00	0.00
Payables Turnover	<0.01	0.00	0.01	0.01	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Asset Turnover	0.00	0.00	0.00	0.00	0.00
Working Capital Turnover Ratio	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle	-83.77K	0.00	-33.41K	-33.41K	0.00
Days of Sales Outstanding	0.00	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	0.00	0.00	0.00	0.00	0.00
Days of Payables Outstanding	83.77K	0.00	33.41K	33.41K	0.00
Operating Cycle	0.00	0.00	0.00	0.00	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	-0.76	-1.23	-1.66	-1.66	-2.14
Free Cash Flow Per Share	-0.76	-1.23	-1.66	-1.66	-2.14
CapEx Per Share	<0.01	0.00	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	-24.35M	0.00	-560.59	-560.59	-936.06
Capital Expenditure Coverage Ratio	-24.35M	0.00	-560.59	-560.59	-936.06
Operating Cash Flow Coverage Ratio	0.00	0.00	0.00	0.00	-32.81
Operating Cash Flow to Sales Ratio	0.00	0.00	0.00	0.00	0.00
Free Cash Flow Yield	-22.28%	-54.08%	-55.20%	-55.20%	-71.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-7.74	-2.88	-1.74	-1.74	-0.53
Price-to-Sales (P/S) Ratio	0.00	0.00	0.00	0.00	0.00
Price-to-Book (P/B) Ratio	0.96	0.41	0.36	0.36	0.33
Price-to-Free Cash Flow (P/FCF) Ratio	-4.46	-1.85	-1.81	-1.81	-1.40
Price-to-Operating Cash Flow Ratio	-5.03	-1.85	-1.81	-1.81	-1.41
Price-to-Earnings Growth (PEG) Ratio	-0.26	0.05	0.02	0.02	>-0.01
Price-to-Fair Value	0.96	0.41	0.36	0.36	0.33
Enterprise Value Multiple	-4.54	-0.33	0.05	0.05	0.28
Enterprise Value	37.11M	5.43M	-622.64K	-622.64K	-5.01M
EV to EBITDA	-4.58	-0.33	0.05	0.05	0.28
EV to Sales	0.00	0.00	0.00	0.00	0.00
EV to Free Cash Flow	-3.09	-0.36	0.05	0.05	0.31
EV to Operating Cash Flow	-3.09	-0.36	0.05	0.05	0.31
Tangible Book Value Per Share	0.85	1.43	1.68	1.68	2.51
Shareholders’ Equity Per Share	3.94	5.51	8.30	8.30	9.14
Tax and Other Ratios
Effective Tax Rate	0.17	0.25	0.12	0.12	0.18
Revenue Per Share	0.00	0.00	0.00	0.00	0.00
Net Income Per Share	-0.49	-0.79	-1.73	-1.73	-5.71
Tax Burden	0.83	0.75	0.88	0.88	0.82
Interest Burden	1.16	0.77	1.29	1.29	2.85
Research & Development to Revenue	0.00	0.00	0.00	0.00	0.00
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	1.54	1.56	0.96	0.96	0.38

Currency in CAD